<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: MicroRNA-21 (miR-21) was reported as being overexpressed in various human cancerous tissues, but its expression in cancerous serum was not unanimous in different laboratories </plain></SENT>
<SENT sid="1" pm="."><plain>On the base of optimizing experimental design and improving trial protocol, we wanted to know whether the circulating microRNA-21 was dysregulated in the common solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using SYBR green real-time quantitative reverse transcription-PCR, we detected the expression of circulating miR-21 in 174 patients with solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and 39 <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects, including <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, we analyzed the associations between miR-21 expression and clinical features of patients </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: miR-21 was significantly overexpressed in human solid cancerous serum relative to <z:mpath ids='MPATH_458'>normal</z:mpath> control (P &lt; 0.001), and its sensitivity and specificity were significantly higher than the currently used <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers </plain></SENT>
<SENT sid="5" pm="."><plain>High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> status </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Circulating miR-21 could serve as a potential broad-spectrum serum-based biomarker for the detection of some solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>